Found 6 matching trials
Safety and Efficacy of IBI188 With Azacitidine in Subjects With Newly Diagnosed Higher Risk MDS PHASE1 The study is to evaluate safety and efficacy of IBI188 in combination with ...
Show More Location
Blood Diseases Hospital Chinese Academy Of Medical Science
Learn More & Join Trial
Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia PHASE1 The study is to evaluate safety, tolerability and composite CR of IBI188 pl...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
IBI188 Combination Therapy in Solid Tumors PHASE1 A Phase Ib study aim to evaluate the efficacy, safety, and tolerability of ...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas PHASE1 This is an open-label, dose escalation, Phase I study to evaluate the safet...
Show More Learn More & Join Trial
A Study Evaluating the Safety and Efficacy of IBI188 in Combination With AZA in Subjects With Newly Diagnosed MDS PHASE1 This is an open-label, phase 1b study to evaluate the safety, tolerability ...
Show More Location
American Oncology Partners of Maryland, PA
Learn More & Join Trial
A Phase 1 Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI188 in Advanced Malignancies PHASE1 This is an open-label, dose escalation, Phase I study to evaluate the safet...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial